المؤلفون: Boris Gorsh, Jenny Willson, Grammati Sarri, Rachel Hughes, Feng Wang, Shannon Ferrante, Thibaud Prawitz, Cosmina Hogea, Rakesh Popat, Attaya Suvannasankha, Venediktos Kapetanakis

المصدر: Advances in Therapy

مصطلحات موضوعية: Oncology, medicine.medical_specialty, MAIC, Matching-adjusted, Survival, Selinexor, Antibodies, Monoclonal, Humanized, Dexamethasone, chemistry.chemical_compound, RRMM, Refractory, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Adverse effect, Multiple myeloma, Original Research, business.industry, Hazard ratio, Standard of Care, General Medicine, Triazoles, medicine.disease, Carfilzomib, Confidence interval, Hydrazines, chemistry, Proteasome inhibitor, Belamaf, Indirect treatment comparison, MAMMOTH, Neoplasm Recurrence, Local, business, Multiple Myeloma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c95b144cdbc63217b7820fb76303c72Test
http://europepmc.org/articles/PMC8523001Test

المؤلفون: Ling Eng Tan, Gerald Seng Wee Chua, Mohamed Ismail Abdul Aziz, Ping-Tee Tan, Fiona Pearce, David Bin-Chia Wu, Liang Lin, Kwong Ng

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, Network Meta-Analysis, Respiratory System Agents, Review, mixed treatment comparison, Muscarinic Antagonists, chronic obstructive pulmonary disease, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Internal medicine, frequentist meta-analysis, Forced Expiratory Volume, Administration, Inhalation, medicine, Humans, 030212 general & internal medicine, anticholinergics, Adrenergic beta-2 Receptor Agonists, Fluticasone, Randomized Controlled Trials as Topic, COPD, biology, business.industry, indirect treatment comparison, Olodaterol, General Medicine, Lama, biology.organism_classification, medicine.disease, respiratory tract diseases, Treatment Outcome, 030228 respiratory system, chemistry, Indacaterol, Vilanterol, Formoterol, Salmeterol, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b00364d6d97de017cce2a5e2fc600fTest
http://europepmc.org/articles/PMC6186767Test

المؤلفون: Hyung-Don Kim, Margherita Rimini, Andrea Casadei-Gardini, Alessandro Cucchetti, Francesca Salani, Gianluca Masi, Yeonghak Bang, Changhoon Yoo, Sara Lonardi, Lorenza Rimassa, Silvia Catanese, Valentina Burgio, Stefano Cascinu, Caterina Vivaldi, Baek-Yeol Ryoo, Mario Domenico Rizzato, Min-Hee Ryu, Antonio Pellino

المساهمون: Casadei-Gardini, A., Rimassa, L., Rimini, M., Yoo, C., Ryoo, B. -Y., Lonardi, S., Masi, G., Kim, H. -D., Vivaldi, C., Ryu, M. -H., Rizzato, M. D., Salani, F., Bang, Y., Pellino, A., Catanese, S., Burgio, V., Cascinu, S., Cucchetti, A.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Pyridines, Targeted therapy, chemistry.chemical_compound, 0302 clinical medicine, Anilides, Cabozantinib, CELESTIAL, Hepatocellular carcinoma (HCC), Indirect treatment comparison, Matching-adjusted indirect comparison (MAIC), Regorafenib, RESORCE, Second-line, Systemic therapy, Adult, Aged, Carcinoma, Hepatocellular, Clinical Trials, Phase III as Topic, Female, Humans, Liver Neoplasms, Middle Aged, Phenylurea Compounds, Progression-Free Survival, Salvage Therapy, Sorafenib, General Medicine, Phase III as Topic, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, medicine.drug, medicine.medical_specialty, Placebo, 03 medical and health sciences, Internal medicine, medicine, Clinical Trials, Second line treatment, business.industry, Proportional hazards model, Carcinoma, Hepatocellular, medicine.disease, Indirect comparison, 030104 developmental biology, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8ee6780c4621c91020e3b72a30aa15Test
http://hdl.handle.net/11568/1111031Test

المؤلفون: Lidia Martin, Jörg Trojan, Yuxin Li, Fabio Piscaglia, Marino Venerito, Renata Zaucha, Florence Marteau, P Mollon, Debashis Sarker, Ho Yeong Lim, Qing Xu, Bruno Daniele

المساهمون: Trojan J., Mollon P., Daniele B., Marteau F., Martin L., Li Y., Xu Q., Piscaglia F., Zaucha R., Sarker D., Lim H.Y., Venerito M.

المصدر: Advances in Therapy

مصطلحات موضوعية: Oncology, Sorafenib, Adult, 030213 general clinical medicine, medicine.medical_specialty, Carcinoma, Hepatocellular, Cabozantinib, Pyridines, Population, Antibodies, Monoclonal, Humanized, Tyrosine kinase inhibitor (TKI), Ramucirumab, Monoclonal antibody (mAb), 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Humans, Pharmacology (medical), Anilides, Hepatocellular carcinoma (HCC), Adverse effect, education, Original Research, Matching-adjusted indirect comparison (MAIC), education.field_of_study, second-line treatment / 2L treatment, business.industry, Liver Neoplasms, Vascular endothelial growth factor (VEGF), Indirect treatment comparison (ITC), General Medicine, medicine.disease, Discontinuation, chemistry, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, alpha-Fetoproteins, Alpha-fetoprotein (AFP), business, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c3aa9afe58ea47cabce4fe25c8f123Test
https://hdl.handle.net/11585/858948Test

المؤلفون: Ines Guerra, V. Valcheva, Bruno Daniele, Jean-Frédéric Blanc, Ghassan K. Abou-Alfa, Florence Marteau, Thomas Yau, Ann-Lii Cheng, P Mollon, Robin Kate Kelley

المصدر: Advances in Therapy

مصطلحات موضوعية: Oncology, Male, Comparative Effectiveness Research, Pyridines, Angiogenesis Inhibitors, Targeted therapy, chemistry.chemical_compound, Medicine, Pharmacology (medical), Anilides, Randomized Controlled Trials as Topic, Original Research, Matching-adjusted indirect comparison (MAIC), Regorafenib, education.field_of_study, Systemic therapy, Liver Neoplasms, General Medicine, Middle Aged, Sorafenib, Progression-Free Survival, Outcome and Process Assessment, Health Care, Hepatocellular carcinoma, Disease Progression, Indirect treatment comparison, Female, Liver cancer, medicine.drug, medicine.medical_specialty, Carcinoma, Hepatocellular, Cabozantinib, Population, Antineoplastic Agents, Second-line, Placebo, CELESTIAL, Internal medicine, Humans, RESORCE, Hepatocellular carcinoma (HCC), Adverse effect, education, Neoplasm Staging, business.industry, Phenylurea Compounds, medicine.disease, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a981f0c42dfcefe14c61194eddda74cTest
https://pubmed.ncbi.nlm.nih.gov/32424805Test

المؤلفون: Weisel, K., Majer, I., DeCosta, L., Oriol, Albert, Goldschmidt, H., Ludwig, H., Campioni, M., Szabo, Z., Dimopoulos, Meletios, Universitat Autònoma de Barcelona

المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Dexamethasone, Bortezomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Proteasome inhibitor treatment duration, Multiple myeloma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, In patient, Matching-adjusted indirect treatment comparison, business.industry, Hazard ratio, Daratumumab, Refractory Multiple Myeloma, Hematology, medicine.disease, Carfilzomib, Treatment Outcome, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Multiple Myeloma, business, Oligopeptides, 030215 immunology, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b56d60dc9d61acc8839745cee8927fTest
https://ddd.uab.cat/record/236099Test

المؤلفون: Eline L. Huisman, Afisi S. Ismaila, Yogesh Punekar, Katya Y. J. Sion, Ian Naya

المصدر: Pulmonary Therapy

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Bayesian analysis, LABA, Placebo, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Comparative efficacy, Randomized controlled trial, law, Respiratory Care, Medicine, COPD, 030212 general & internal medicine, Original Research, business.industry, Inhaler, Olodaterol, LAMA, medicine.disease, respiratory tract diseases, Meta-analysis, 030228 respiratory system, chemistry, Anesthesia, Combination bronchodilator, Indirect treatment comparison, Formoterol, Salmeterol, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b452c88fc87327dc87574ff9647604Test
http://europepmc.org/articles/PMC6964204Test

المؤلفون: Amit Ahuja, S Kamra, Japinder Gill, Adil Daud, Lei Chen

المصدر: Journal of hematology & oncology, vol 10, iss 1
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-9 (2017)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Indoles, Cardiorespiratory Medicine and Haematology, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Cobimetinib, Oximes, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Medicine, Neoplasm Metastasis, Vemurafenib, Melanoma, Cancer, Randomized Controlled Trials as Topic, Trametinib, Aged, 80 and over, Sulfonamides, MEK inhibitor, Dabrafenib, Hazard ratio, Imidazoles, lcsh:Diseases of the blood and blood-forming organs, Hematology, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Treatment Outcome, 030220 oncology & carcinogenesis, Indirect treatment comparison, Female, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Pyridones, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Pyrimidinones, and over, Metastatic melanoma, lcsh:RC254-282, 03 medical and health sciences, Young Adult, Clinical Research, Internal medicine, Humans, Molecular Biology, Aged, lcsh:RC633-647.5, business.industry, Research, medicine.disease, Surgery, 030104 developmental biology, chemistry, Azetidines, Skin cancer, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ff982c4dea63d273cf0b21f0ac22b6Test
https://escholarship.org/uc/item/0489m9fgTest

المؤلفون: Philippe Van Wilder

المصدر: Frontiers in Pharmacology, Vol 3 (2012)
Frontiers in Pharmacology

مصطلحات موضوعية: health benefit, media_common.quotation_subject, Health protection, Regulation 1394/2007, chemistry.chemical_compound, Human use, advanced therapy, exemption, Medicine, Pharmacology (medical), Quality (business), media_common, Pharmacology, Relative efficacy, business.industry, indirect treatment comparison, lcsh:RM1-950, Authorization, Exploratory analysis, ATMP, Product (business), lcsh:Therapeutics. Pharmacology, chemistry, Risk analysis (engineering), Perspective Article, business, patient outcome

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8d1d5ef86b71426ca6d3db63c85e9a7Test
https://doi.org/10.3389/fphar.2012.00012Test

المؤلفون: Kristian Thorlund, Edward J Mills, Michaela Lion, Eric Druyts, Samantha Humphreys, Curtis Cooper

المصدر: Clinical Epidemiology

مصطلحات موضوعية: hepatitis C virus, Pathology, medicine.medical_specialty, multiple treatment comparison, Epidemiology, Treatment comparison, Psychological intervention, 030204 cardiovascular system & hematology, DIRECT ACTING ANTIVIRALS, Telaprevir, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Chronic hepatitis, Boceprevir, medicine, Clinical Epidemiology, 030212 general & internal medicine, Intensive care medicine, business.industry, indirect treatment comparison, Methodology, Treatment efficacy, 3. Good health, meta-analysis, chemistry, Meta-analysis, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2087751450660a26885b7e700f228416Test
https://doi.org/10.2147/clep.s44273Test